Cargando…
Thymoquinone Inhibits the CXCL12-Induced Chemotaxis of Multiple Myeloma Cells and Increases Their Susceptibility to Fas-Mediated Apoptosis
In multiple myeloma (MM), malignant plasma cells reside in the bone marrow, where they accumulate in close contact with stromal cells. The mechanisms responsible for the chemotaxis of malignant plasma cells are still poorly understood. Thus, we investigated the mechanisms involved in the chemotaxis...
Autores principales: | Badr, Gamal, Lefevre, Eric A., Mohany, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164673/ https://www.ncbi.nlm.nih.gov/pubmed/21912642 http://dx.doi.org/10.1371/journal.pone.0023741 |
Ejemplares similares
-
Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice
por: Badr, Gamal, et al.
Publicado: (2011) -
Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-(XL )expression
por: Badr, Gamal, et al.
Publicado: (2011) -
Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070
por: O'Boyle, G, et al.
Publicado: (2013) -
Regulation of T cell chemotaxis by CXCL4
por: Woller, G, et al.
Publicado: (2009) -
CXCL12-stimulated lymphocytes produce secondary stimulants that affect the surrounding cell chemotaxis
por: Kurowarabe, Kaoru, et al.
Publicado: (2021)